The Dana-Farber/Harvard Cancer Center Ovarian SPORE Grand Rounds offers a multidisciplinary HMS CME conference open to DF/HCC institutions (BWH, BIDMC, BCH, HSPH, HMS and MGH). The series offers remote participation through Zoom. The series hosts renowned local, national and international speakers presenting impactful findings in ovarian cancer. Note: there will be no recordings for these talks, and all talks begin at 3PM EST, unless mentioned otherwise.
There are currently no upcoming talks. Please check this page again later.
Dr. Bast is Vice President for Translational Research at The University of Texas MD Anderson Cancer Center where he holds the Harry Carothers Wiess Distinguished University Chair for Cancer Research. His office facilitates translation of new strategies, drugs and devices from the laboratory to the clinic, as well as the movement of human material and data from the clinic to laboratory. He received his education at Wesleyan University, Harvard Medical School, Johns Hopkins Hospital, the National Cancer Institute, Peter Bent Brigham Hospital and Dana-Farber Cancer Institute. Before joining the MD Anderson faculty in 1994 he served on the faculties of Harvard Medical School and Duke University Medical Center where he was Director of the Duke Comprehensive Cancer Center. [Read More]
Dr. Odunsi is a gynecologic oncologist whose research focuses on understanding the mechanisms of immune recognition and tolerance in ovarian cancer and translating these findings to immunotherapy clinical trials. He pioneered the development of antigen-specific vaccine therapy and “next generation” adoptive T-cell immunotherapies to prolong remission rates in women with ovarian cancer. [Read More]
Dr. David Huntsman (MD, FRCPC, FCCMG) is the Dr. Chew Wei Memorial Professor of Gynaecologc Oncology, holds the Canada Research Chair (Tier 1) in Molecular and Genomic Pathology, and is a Professor in the Departments of Pathology and Laboratory Medicine and Obstetrics and Gynaecology at UBC. He is also the co-Founder and Director of OVCARE, BC's multidisciplinary gynecologic cancer research team. [Read More]
Panagiotis (Panos) A Konstantinopoulos, MD, PhD is Director of Translational Research and attending oncologist in the Division of Gynecologic Oncology at Dana-Farber Cancer Institute, and an Associate Professor of Medicine at Harvard Medical School. His translational research career focuses on ovarian cancer and other gynecologic malignancies with an important niche in the areas of DNA Damage and Repair and Immunotherapy. His work has focused on unraveling mechanisms of resistance to chemotherapy and targeted agents, developing the rationale and preclinical data for novel drug combinations in ovarian cancer, and on identification of novel diagnostic and predictive biomarkers of therapeutic response in gynecologic cancers as well investigating their mechanistic implication in carcinogenesis. [Read More]